| 000 | 01712 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513105442.0 | ||
| 264 | 0 | _c19970317 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0893-228X | ||
| 024 | 7 |
_a10.1021/tx960058k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHissink, A M | |
| 245 | 0 | 0 |
_aDifferences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment. _h[electronic resource] |
| 260 |
_bChemical research in toxicology _cDec 1996 |
||
| 300 |
_a1249-56 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aChlorobenzenes _xpharmacokinetics |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInsecticides _xpharmacokinetics |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 700 | 1 | _aOudshoorn, M J | |
| 700 | 1 | _aVan Ommen, B | |
| 700 | 1 | _aHaenen, G R | |
| 700 | 1 | _aVan Bladeren, P J | |
| 773 | 0 |
_tChemical research in toxicology _gvol. 9 _gno. 8 _gp. 1249-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/tx960058k _zAvailable from publisher's website |
| 999 |
_c8943374 _d8943374 |
||